TNFRSF9 and neoplasm: The high frequency of CD137 + CD8 + T cells before treatment may indicate that patients had more tumor antigen-specific, highly inhibited, exhausted CD8 + T cells and a poor response to neoadjuvant chemoimmunotherapy.